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Background: Upper respiratory tract infection (URTI) has a significant healthcare burden worldwide. Considerable
resources are consumed through health care consultations and prescribed treatment, despite evidence for little or
no effect on recovery. Patterns of consultations and care including use of symptomatic medications and antibiotics
for upper respiratory tract infections are poorly described.
Methods: We performed a retrospective review of computerized clinical data on patients presenting to all public
primary care clinics in Hong Kong with symptoms of respiratory tract infections. International Classification of
Primary care (ICPC)codes used to identify patients included otitis media (H71), streptococcal pharyngitis (R72), acute
URTI (R74), acute sinusitis (R75), acute tonsillitis (R76), acute laryngitis (R77), and influenza (R80). Sociodemographic
variables such as gender, age, chronic illness status, attendance date, type and duration of drug prescribed were
also collected.
Results: Of the 5,529,755 primary care consultations for respiratory symptoms from 2005 to 2010, 98% resulted in a
prescription. Prescription patterns of symptomatic medication were largely similar across the 5 years. In 2010 the
mean number of drugs prescribed per consultation was 3.2, of which the commonly prescribed medication were
sedating antihistamines (79.9%), analgesia (58.9%), throat lozenges (40.4%) and expectorant cough syrup (33.8%).
During the study period, there was an overall decline in antibiotic prescription (8.1% to 5.1%). However, in
consultations where the given diagnosis was otitis media (H71), streptococcal pharyngitis (R72), acute sinusitis (R75)
or acute laryngitis (R76), over 90% resulted in antibiotic prescription.
Conclusion: There was a decline in overall antibiotic prescription over the study period. However, the use of
antibiotics was high in some conditions e.g. otitis media and acute laryngitis a. Multiple symptomatic medications
were given for upper respiratory tract infections. Further research is needed to develop clinical and patients
directed interventions to reduce the number of prescriptions of symptomatic medications and antibiotics that
could reduce costs for health care services and iatrogenic risk to patients.
Keywords: Upper respiratory tract infection, Primary care, Pharmacology* Correspondence: carmenwong@cuhk.edu.hk
1Division of Family Medicine, School of Public Health & Primary Care, Chinese
University of Hong Kong, Shatin, Hong Kong
4Jockey School of Public Health, Prince of Wales Hospital, Room 408, 32
Ngan Shing Street, Shatin, NT, Hong Kong
Full list of author information is available at the end of the article
© 2014 Kung et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Kung et al. BMC Family Practice 2014, 15:95 Page 2 of 7
http://www.biomedcentral.com/1471-2296/15/95Background
Respiratory infections are the commonest health problem
encountered in primary care worldwide [1-3], amounting
to between 16% to over 60% of attendances depending on
locality [4,5]. Upper respiratory tract infection (URTI) is
an important cause of reduced activity days, school and
work loss, impaired school performance, and increased
healthcare utilization [6], resulting in substantial economic
burden.
There is little data on actual prescribing practice for
URTI in Asia. Evidence shows that symptomatic medi-
cations including antibiotics are of marginal or no bene-
fit [7-13]. However, there are widespread variations in
URTI management. A telephone survey of Auckland
GPs found that 95% would, on occasions, prescribe as-
needed medications (instructions for patient to fill pre-
scriptions if condition worsens), including antibiotics
[14]. In a European study, the number of medication
types per patient varied from 0.82 to 3.55 per patient
per year [15]. Interestingly, the antibiotic prescription
rate in this European study did not vary with the overall
medication prescription rate. A study in Zimbabwe
highlighted widespread non-evidence based prescribing
for URTI patients [16]. The actual prescribing practice
among Chinese primary care physicians for URTI symp-
toms has not previously been investigated, although an-
ecdotal observations show that medications for
symptomatic relief are commonly used. Understanding
the characteristics of patients who consult with URTI
symptoms and the prescribing practices of primary care
clinicians could identify opportunities for intervention
such as reducing unnecessary prescriptions of antibiotic
and symptomatic medication and reallocating resources
for other medical conditions in primary care such as
chronic disease management.
We therefore reviewed the characteristics of patients
attending Hong Kong’s public primary care clinics (PPCCs)
with URTI symptoms, and the types of medications clini-
cians prescribed for URTI symptoms.
Methods
We performed a retrospective review of computerized
clinical data on patients presenting to PPCCs with upper
respiratory tract symptoms between 1st January 2005 and
31st December 2010. Upper respiratory tract symptoms
were defined by specific ICPC (International Classification
of Primary Care) codes agreed upon by an expert panel of
local primary care physicians including:
 H71 – otitis media
 R72 – streptococcal pharyngitis
 R74 – acute upper respiratory tract infection
 R75 – acute sinusitis
 R76 – acute tonsillitis R77 – acute laryngitis
 R80 – influenza
There are 74 PPCCs in Hong Kong covering the entire
population 7 million, with over 5 million attendances an-
nually [17]. Consultations fees are subsidized for per-
manent residents (patient pays USD5.8 per consultation,
inclusive of medications and investigations), while spe-
cific populations (government workers and those on fi-
nancial assistance) receive free consultations. Existing
literature suggests that less than 100,000 attendances are
made to local emergency departments for non-urgent
respiratory tract infections annually [18,19], while 26%
of private sector consultations (accounting for 50% of
Hong Kong’s primary care) are related to respiratory tract
infections [1].
Data on gender, age, chronic illness status, attendance
date, type and duration of drug prescribed for URTI were
extracted from the system-wide electronic record system
(Clinical Data Analysis & Reporting System [CDARS]).
There is no information from CDARS for patients’
financial status; nevertheless, those requiring financial
assistance from the government can be identified separ-
ately from those paying the usual fee. Previous publica-
tions using CDARS have demonstrated the accuracy and
completeness of the data retrieved from this system [20].
We defined a repeat attendance for the same URTI
episode (which we considered as the same illness epi-
sode) as any attendances for URTI symptoms within
28 days of the previous URTI attendance. Medications
were grouped into specific drug classes, including anal-
gesia, antibiotics, antihistamines, cough syrup, mucolytic,
s α-agonists, β-agonists, theophylline and other including
throat lozenges, lysozyme.
All statistical analysis was performed using SPSS ver-
sion 18.0 for Windows. Descriptive statistics were cal-
culated using mean and range. Chi-square test was used
to compare categorical variables across the different
years. All p values <0.05 were regarded as statistically
significant.
This study was approved by the Clinical Research Ethics
Committee of the Chinese University of Hong Kong and
New Territories East Cluster of the Hospital Authority.
Results
There were 5,529,755 attendances for RTIs from 2005 to
2010. Patient demographics and the conditions diagnosed
are summarized in Table 1.
Patient presentation
There were 5,529,755 consultations for URTI symptoms
in the study period for the patient population of
1,181,816 [21]. The distribution of annual attendances
was similar across the six years with the majority
Table 1 Patient demographics and diagnosed conditions
Year of attendance
2005 2006 2007 2008 2009 2010
Annual attendance for all
respiratory infections
997768 937686 923504 966739 813874 895978
Distribution of annual attendances
number (number of patients)
1 attendance 59.9% (319154) 59.7% (296239) 57.5% (269327) 56.7% (274308) 59.4% (253995) 57.8% (264110)
2-4 attendances 34.2% (181992) 34.0% (168824) 35.3% (165316) 35.9% (173343) 34.3% (146461) 35.3% (161307)
5-8 attendances 4.9% (26157) 5.2% (25765) 5.8% (27347) 6.1% (29305) 5.2% (22411) 5.8% (26308)
>8 attendances 1.0% (5495) 1.1% (5359) 1.3% (6034) 1.3% (6517) 1.1% (4735) 1.2% (5549)
Patient headcount 532798 496187 468024 483473 427602 457274
Mean attendance per patient per year 1.9 1.93 2.0 2.0 1.9 2.0
Mean age (years) 41.1 41.2 42.9 43.8 44.3 45.6
Gender
Female 56.4% 56.1% 56.9% 57.0% 56.4% 57.0%
On government subsidy 20.7% 20.4% 19.5% 21.0% 21.4% 21.0%
Chronic illness
Ischaemic heart disease 1.6% (8440) 1.5% (7578) 1.5% (7219) 1.6% (7594) 1.5% (6324) 1.5% (6729)
Hypertension 22.8% (121304) 21.8% (108344) 23.2% (108397) 23.9% (115461) 23.9% (102066) 24.0% (109558)
Stroke 1.6% (8290) 1.4% (7191) 1.5% (7151) 1.6% (7580) 1.4% (6128) 1.4% (6392)
Prostatism 2.6% (13905) 2.7% (13160) 2.8% (13219) 2.9% (14072) 2.9% (12610) 2.9% (13374)
Asthma 2.9% (15264) 3.0% (14904) 3.2% (14866) 3.1% (15146) 3.2% (13563) 2.9% (13358)
COPD 1.5% (7797) 1.4% (7191) 1.4% (6679) 1.3% (6458) 1.3% (5595) 1.1% (5197)
Coded conditions
H71 (otitis media) 0.29% 0.34% 0.31% 0.33% 0.33% 0.33%
R72 (streptococcal 0.02% 0.03% 0.02% 0.03% 0.04% 0.04%
pharyngitis) 97.35% 96.99% 97.07% 96.30% 95.42% 94.25%
R74 (acute URTI) 0.15% 0.17% 0.20% 0.21% 0.26% 0.25%
R75 (acute sinusitis) 0.49% 0.53% 0.44% 0.67% 0.88% 1.02%
R76 (acute tonsillitis) 0.04% 0.04% 0.03% 0.03% 0.04% 0.07%
R77 (acute laryngitis) 0.26% 0.33% 0.29% 0.27% 0.69% 0.97%
R80 (influenza)
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of upper respiratory tract infections. Over a third of the
patients (approximately 35%) attended 2-4 times per
year. There was a 16% drop in attendances in 2009.
Overall, there was a significant increase (p < 0.001) in
the mean number of annual attendances per patient.
The mean age of presentation shows a steady increase
from 41.1 to 45.6 years from 2005 -2010. Patients were
more likely to be female (approx 57%) and on average
one fifth of those presenting were on government sub-
sidy. Over 94% were coded as upper respiratory tract in-
fection (R74). Over the 6 years, there was a significant
increase (p < 0.001) in the number of patients coded with
non-R74 conditions.Prescription of medication
Of the 5,529,755 primary care consultations for URTI
symptoms from 2005 to 2010, 98% resulted in a pre-
scription of at least one medication (Table 2). Prescrip-
tion patterns of symptomatic medication were largely
similar across the 5 years, but there was a small but
significant rise in the number of drugs given per con-
sultation (p < 0.001). The most commonly prescribed
medications were sedating antihistamines (79.9%), anal-
gesia (58.9%), throat lozenges (40.4%) and expectorant
cough syrup (33.8%). During the study period, there was
a significant decline in antibiotic prescription from 8.1%
to 5.1% (p < 0.001). However, in consultations, where
the given diagnosis was otitis media (H71), streptococcal
Table 2 Details on drugs prescribed
Year of attendance
2005 2006 2007 2008 2009 2010
Mean number of drugs 3.1 3.1 3.2 3.2 3.2 3.2
Number of drug items per prescription
0 2.7% 2.7% 2.3% 1.3% 1.3% 1.1%
1 5.7% 5.5% 5.1% 5.1% 5.5% 5.0%
2 21.2% 20.4% 19.6% 19.7% 19.8% 18.3%
3 34.6% 33.8% 33.3% 33.0% 32.4% 32.1%
4 27.8% 28.5% 29.7% 30.9% 31.0% 33.0%
>4 8.1% 9.2% 10.0% 10.0% 10.0% 10.5%
Proportion of prescriptions containing Current evidence
Analgesics
Paracetamol 58.3% 60.1% 59.8% 59.1% 58.7% 58.9% May reduce fever
NSAIDs 3.0% 3.6% 4.2% 4.3% 4.5% 4.9% May reduce pain
COX-II inhibitors 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% No evidence
Antibiotics 8.1% 8.1% 6.8% 4.9% 4.4% 5.1%
Antihistamines
Sedating 81.1% 80.1% 82.3% 82.4% 80.8% 79.9% Ineffective
Non-sedating 0.5% 0.3% 0.3% 0.3% 0.6% 1.2%
Cough syrup
Expectorant 36.8% 35.6% 36.3% 36.3% 34.0% 33.8% Not recommended in children
Codeine 7.1% 6.9% 6.7% 6.5% 6.6% 6.3% Limited evidence
Mucolytic 20.9% 22.2% 23.0% 24.0% 24.0% 25.0% May reduce symptoms
Oral α-agonist 0.6% 0.4% 0.3% 0.2% 0.2% 0.2% Modest effect in adults
Oral β-agonist 4.4% 4.7% 4.2% 4.1% 3.7% 4.1% No evidence
Theophylline 1.1% 1.0% 1.0% 0.9% 0.8% 0.9% No evidence
Others
Throat lozenges 34.7% 34.9% 35.6% 37.5% 39.9% 40.4% No evidence
Lysozyme 10.6% 11.8% 13.8% 14.5% 14.9% 15.6% No evidence
Neozep 0.6% 0.3% 0.3% 0.2% 0.0% 0.1%
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gitis (R76), over 90% resulted in antibiotic prescription
(Table 3). Almost 50% of patients diagnosed with influenza
were prescribed antibiotics. The proportion was much less
among those coded with R74 (acute URTI).Table 3 Proportion of antibiotic prescribed in different URTIs
Year H71 R72 R74
2005 94.4% (2816) 89.2% (213) 6.5% (957615) 9
2006 95.4% (3135) 80.6% (294) 6.3% (897381) 8
2007 95.2% (2798) 81.7% (164) 5.1% (889038) 8
2008 94.1% (3179) 93.9% (245) 2.6% (937252) 9
2009 94.4% (2683) 95.5% (352) 1.8% (782692) 9
2010 94.4% (3044) 97.8% (320) 1.9% (858979) 9
Bracketed values indicate the number of attendances where the specified ICPC codDiscussion
Main study findings
Consultations for URTI symptoms account for almost
20% of attendances per year in Hong Kong’s public pri-
mary care (around 900,000 out of 5 million attendancesCondition
R75 R76 R77 R80
0.7% (1523) 95.2% (4776) 23.9% (348) 54.0% (2556)
6.1% (1529) 96.0% (4915) 25.4% (378) 52.8% (3087)
5.0% (1788) 94.7% (4005) 26.9% (283) 50.6% (2669)
1.6% (2024) 96.7% (6543) 59.1% (281) 47.0% (2623)
2.0% (2138) 97.8% (7233) 68.6% (338) 43.1% (5697)
1.3% (2317) 97.9% (9317) 73.6% (658) 48.2% (8882)
e was assigned.
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which coincides with the swine flu outbreak that year,
where patients with influenza like illness were advised to
go to designated fever clinics. There is an increasing
mean age of patients presenting to primary care for
upper respiratory tract infections which may reflect the
increasing age of the population and those presenting to
primary care. 98% of consultations were associated with
a prescription, which on average included four drug clas-
ses. Antibiotics were prescribed in 5% of consultations.
Antibiotic prescribing
The overall antibiotic prescription rate observed in this
study was much lower than in other countries [22-25].
Although patients with uncomplicated URTIs (R74) com-
prise the large majority of the population, it appears that
the overall volume of antibiotics prescribed remains low.
However, nearly all those coded with H71 (otitis media),
R72 (streptococcal pharyngitis), R75 (acute sinusitis) and
R76 (acute tonsillitis) were almost always prescribed anti-
biotics, with an increasing trend among R72 and R77. Fur-
thermore, around 50% of those diagnosed with influenza
(R80) were also prescribed with antibiotics. Prescribing
pressure [26] from patients may be an issue, especially
among those with more troubling symptoms. This could
also reflect clinicians’ ‘coding creep’ or ‘diagnostic drift’
with the tendency to use non-R74 codes in consultations
where antibiotics were prescribed. Further education and
training in terms of diagnosis, management and use of
correct coding may need to be instated. Whilst financial
incentive is an important contributory factor for ‘coding
creep’ in some countries [27-29], this is not an issue in
Hong Kong where there is no pay-for-performance system
in place. Further education of doctors in the appropriate
management of otitis media, streptococcal pharyngitic,
acute sinusitis and acute tonsillitis may help to reduce
unnecessary antibiotic prescription.
Symptomatic drug utilization
At least 3 medications are prescribed for each URTI epi-
sode. This is higher than the URTI drug prescription
patterns of Dutch doctors, where a mean of 0.8 drugs
were prescribed per patient. Possible explanations for a
higher prescription number may be related to the nature
of the Hong Kong healthcare system, where consultation
fees in PPCCs are heavily subsidized and includes the
cost of medication, patients’ relatively low self medica-
tion rate [30] and high expectations for receiving a pre-
scription for medication during consultations [31]. The
slight increase in the number of medications prescribed
coincided with an increase in annual attendances per pa-
tient for URTI, suggesting that this prescribing habit may
be encouraging patients to consult. Although one previous
European study indicated that medication prescribingrates did not vary with antibiotic prescription rate [15],
further research would be warranted in view of the overall
low antibiotic prescription volume.
A large variety of symptomatic medications were pre-
scribed, including α and β-agonists, lysozyme and mu-
colytics. There is little empirical evidence that these
medicines are effective for URTI [32-35]. Anecdotally,
it is not uncommon for patients to request a medica-
tion for each symptom they experience, which may help
explain why patients are prescribed antitussives, anti-
histamines, mucolytics and throat lozenges. Among these
prescriptions, 80% were on sedating antihistamines; 6%
were given opioid containing medications; and a minority
was prescribed theophyllines, α-agonists or β-agonists.
There is a need for further research on the expectations
of symptomatic medication prescriptions as recipients
of these medications included children, and patients
with chronic disease in which medication side effects
could be detrimental e.g. cardiac diseases, prostatic symp-
toms or respiratory problems [36-39].Implication for health service provision and future
research
Compared with European countries [40-43], Hong Kong’s
public primary care appears to exhibit low antibiotic pre-
scribing behaviour for symptoms of upper respiratory tract
infections. On the other hand, the prescription rate for
non-antibiotic medications is exceptionally high. It may
be that prescription of symptomatic medication has
managed to displace the expectation of antibiotic pre-
scription. However, symptomatic drug prescription is
high, and is estimated to cost the public healthcare
system over 1.2 million US dollars per year. Other costs
including PPCCs’ facilities and human resources, as well
as the societal impact of health services utilization for
URTI have not been included.
Previous studies have shown that a significant propor-
tion of primary care physicians believe patients should
be empowered to self manage uncomplicated URTI [44].
Nevertheless, many patients continue to consult doctors
within the first two days of their illnesses [30,31] despite
its self-limiting nature. Public health initiatives are there-
fore needed in order to promote self-management and
appropriate indications for help seeking. The gap between
clinical evidence for pharmacological intervention, doc-
tors’ prescribing behavior and patient expectation must
also be addressed in order to safeguard patient well-
being and the appropriate use of health care resources.
Primary care physicians can play an active role to em-
power patients to self-manage symptoms and in redu-
cing the reliance on unnecessary medications whenever
appropriate. Further studies looking into cultural differ-
ences in expectations and management of URTI like
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interventions.Strengths and limitations of this study
This is the first study of patient characteristics and
prescribed medication among patients presenting to
public primary care clinics with URTIs in the South
China Region. The availability of electronic patient
data from all PPCCs in Hong Kong ensured coverage
of all patients in the public primary care setting, allowing
an accurate analysis into the health services utilization
related to URTIs. Internal audits within the Hospital
Authority (unpublished data) have indicated that the
ICPC coding rate among PPCCs is generally over 90%.
Two studies examining ICPC coding accuracy over the
recent few years [45,46] have shown that 96% to 98% of
cases are coded accurately, especially if the case is not
complex. These imply that the data obtained for this
study accurately reflects the public primary care situation
in our locality.
Those who utilize public clinics in primary care are
more likely to be of lower socio-economic status, elderly
and individuals with chronic conditions [47], this is
reflected in our study where one fifth is on financial as-
sistance and the increasing age of presentation. How-
ever, results do not include consultations in the private
sector which is likely to see patients who are more afflu-
ent and younger. Meanwhile this study has important
implications as older people are more prone to drug-
drug interactions and adverse events from the prescrip-
tions of medications for URTI. Moreover, as there is a
high rate of ‘doctor shopping’ among patients in pri-
mary care in Hong Kong, this pattern of high utilization
of symptomatic prescriptions for URTI in Hong Kong is
likely to be common among most patients consulting
primary care in Hong Kong, both in the private sector
and in government run clinics given similar expectations.Conclusions
Overall the rate of antibiotic prescription for patients
attending Hong Kong’s public primary care is low,
although the rate is high among those diagnosed with
otitis media, pharyngitis, sinusitis and tonsillitis. On the
other hand, the number symptomatic medications pre-
scribed is high, and its relationship with increasing doc-
tor consultations and low overall antibiotic prescription
need to be further explored. Gaps have been identified
between primary care practice and evidence based man-
agement of upper respiratory tract infections. There is a
huge potential to save resources on inappropriate anti-
biotic use, unnecessary prescription of symptomatic medi-
cation and consultation appointments through doctor and
patient education.Competing interests
The authors declare that they have no competing interests.
Author contributions
KK/CW conceptualised the whole study. KK researched data and wrote the
manuscript, with further analysis performed by CKYC. CW/SYSW/AL/SG/CCB
reviewed the manuscript. CCB contributed to discussion and reviewed the
manuscript. All authors declare that there are no financial relationships with
any organisations that might have an interest in the submitted work, and
that no presentations have been made for this research. All authors read and
approved the final manuscript.
Acknowledgements
This work was supported by the primary care team at the Chinese University
of Hong Kong, without contribution from any external funding sources.
Author details
1Division of Family Medicine, School of Public Health & Primary Care, Chinese
University of Hong Kong, Shatin, Hong Kong. 2Department of Family
Medicine, the Hospital Authority, Kowloon, Hong Kong. 3Department of
General Practice, Cardiff University, Cardiff, UK. 4Jockey School of Public
Health, Prince of Wales Hospital, Room 408, 32 Ngan Shing Street, Shatin, NT,
Hong Kong.
Received: 13 January 2014 Accepted: 29 April 2014
Published: 13 May 2014
References
1. Lo Y, Lam C, Lam T, Lee R, Chiu B, Tang J, Chui B, Chao D, Lam A, Chan K:
Hong Kong primary care morbidity survey 2007-2008. HK Pract 2010,
32:17–26.
2. Hak E, Rovers M, Kuyvenhoven M, Schellevis F, Verheij T: Incidence of
GP-diagnosed respiratory tract infections according to age, gender and
high-risk co-morbidity: the Second Dutch National Survey of General
Practice. Fam Pract 2006, 23(3):291–294.
3. Fleming D, Smith G, Charlton J, Charlton J, Nicoll A: Impact of infections on
primary care - greater than expected. Commun Dis Public Health 2002,
5(1):7–12.
4. Lam W, Ho K, Kwok K, Tsang L: Morbidity pattern in four government
general practice clinics using the International Classification of Primary
Care (Revised Edition) (ICPC-2) coding. HK Pract 2006, 28:363–375.
5. CDARS: Clinical Decision Analysis Reporting System. Hong Kong: Department
of Family Medicine, New Territories East Cluster, Hospital Authority. Last
accessed 12 Jul 2011.
6. Nichol K, D’Heilly S, Ehlinger E: Burden of upper respiratory illnesses
among college and university students: 2002-2003 and 2003-2004
cohorts. Vaccine 2006, 24(44–46):6724–6725.
7. Taverner D, Latte J: Nasal decongestants for the common cold [update of
Cochrane Review]. 2007, (1):CD001953.
8. Kernan W, Viscoli C, Brass L: Phenylpropanolamine and the risk of
hemorrhagic stroke. N Engl J Med 2000, 343:1826–1832.
9. Arroll B, Kenealy T: Are antibiotics effective for acute purulent rhinitis?
Systematic review and meta-analysis of placebo controlled randomised
trials. BMJ 2007, 333:279.
10. Fahey T, Stocks N, Thomas T: Systematic review of the treatment of upper
respiratory tract infection. Arch Dis Child 1998, 79:225–230.
11. Sutter AI, Lemiengre M, Campbell H, Mackinnon HF: Antihistamines for the
common cold. Cochrane Database Syst Rev 2009, (4):CD001267.
12. Yoder K, Shaffer M, La Tournous S: Child assessment of
dextromethorphan, diphenhydramine, and placebo for nocturnal cough
due to upper respiratory infection. Clin Pediatr 2006, 45:633–640.
13. Lam C: Rational prescribing for upper respiratory tract infections.
HK Pract 2002, 24:298–304.
14. Arroll B, Goodyear-Smith F: General practitioner management of upper
respiratory tract infections: when are antibiotics prescribed? NZJM 2000,
493–496.
15. Rosman S, Le Vaillant M, Schellevis F, Clerc P, Verheij R, Pelletier-Fleury N:
Prescribing patterns for upper respiratory tract infections in general
practice in France and in the Netherlands. Eur J of Pub Health 2008,
18(3):312–316.
Kung et al. BMC Family Practice 2014, 15:95 Page 7 of 7
http://www.biomedcentral.com/1471-2296/15/9516. Trap B, Hansen E: Treatment of upper respiratory tract infections – a
comparative study of dispensing and non-dispensing doctors. J Clin
Pharma Therapeut 2002, 27:289–298.
17. Statistics & Workforce Planning Department, Strategy & Planning Division,
Hospital Authority Head Office: GOP Service Portfolio 2012. Hong Kong
Hospital Authority; 2012.
18. Lee A, Lau F, Hazelett C, Kam C, Wong P, Wong TW, Chow S: Morbidity
patterns of non-urgent patients attending accident and emergency
departments in Hong Kong: cross-sectional study. HKMJ 2001, 7:131–138.
19. Law C, Yip P: Acute care service utilisation and the possible impacts of a
user-fee policy in Hong Kong. HKMJ 2002, 8:348–353.
20. Wong M, Jiang J, Tang J, Lam A, Fung H, Mercer S: Health services
research in the public healthcare system in Hong Kong: An analysis of
over 1 million antihypertensive prescriptions between 2004-2007 as an
example of the potential and pitfalls of using routinely collected elec-
tronic patient data. BMC Health Serv Res 2008, 8:138.
21. Census and Statistics Department: The Government of the Hong Kong Special
Administration Region. Population Census; 2006. http://www.statistics.gov.hk/
pub/B11200512006XXXXB0400.pdf. Last accessed 8 May 2014.
22. Cheong L, Kwok C, Aljunid S, Cheah M: Antibiotic prescription in upper
respiratory tract infections. Asia Pacfici Family Medicine 2004, 3(1–2):38–45.
23. Gonzales R, Steiner J, Sande M: Antibiotic prescribing for adults with
colds, upper respiratory tract infections, and bronchitis by ambulatory
care physicians. JAMA 1997, 278(11):901–904.
24. Hui L, Li X, Zeng X, Dai Y: Patterns and determinants of use of antibiotics
for acute respiratory tract infection in children in China. Paed Infect Dis J
1997, 16(6):560–564.
25. Arustiyono: Promoting rational use of drugs at the community health centres in
Indonesia. WHO World Bank Health Project IV; 1999. http://archives.who.int/
prduc2004/Resource_Mats/Asia_papers/PROMOTING%20RATIONAL%20USE%
20OF%20DRUGS%20IN%20INDONESIA.htm. Last accessed 8 May 2014.
26. Stivers T: Prescribing under pressure: parent-physician conversations and
antibiotics. Oxford; New York: Oxford University Press; 2007:221.
27. Pongpirul K, Walker DG, Rahman H, Robinson C: DRG coding practice: a
nationwide hospital survey in Thailand. BMC Health Serv Res 2011,
11(1):290.
28. Simborg DW: DRG Creep: A New Hospital-Acquired Disease. N Engl J Med
1981, 304(26):1602–1604.
29. Agrawal S: Educating Physicians About Responsible Management of
Finite Resources. JAMA 2013, 309(11):1115.
30. Lee A, Siu S, Lam A, Tsang C, Kung K, Li P: The concepts of family doctor
and the factors affecting choice of family doctors among Hong Kong
people. Hong Kong Med J 2010, 16:18–25.
31. Chan C: What do patients expect from consultations for upper
respiratory tract infections? Fam Pract 1996, 13:229–235.
32. Duijvestijn Y, Mourdi N, Smucny J, Pons G, Chalumeau M: Acetylcysteine
and carbocysteine for acute upper and lower respiratory tract infections
in paediatric patients without chronic broncho-pulmonary disease.
Cochran Database Syst Rev 2009, 1:CD003124.
33. Smith S, Schroeder K, Fahey T: Over-the-counter (OTC) medications for
acute cough in children and adults in ambulatory settings. Cochran
Database Syst Rev 2008, 1:CD001831.
34. Kim S, Chang Y, Cho H, Hwang Y, Moon Y: Non-steroidal anti-
inflammatory drugs for the common cold. Cochran Database Syst Rev
2009, 3:CD006362.
35. Arroll B: Respiratory disorders (acute) - common cold. Clinical Evidence
2011, 03:1510.
36. Hong Kong Department of Health, Pharmaceutical Registration Section:
Drug alert on the use of oral liquid cough medicines containing codeine. Hong
Kong: Department of Health; 2010.
37. Church M, Maurer M, Simons F, Bindslev-Jensen C, van Cauwenberge P,
Bousquet J, Holgate ST, Zuberbier T: Risk of first-generation H1- antihistamines:
a GA2LEN position paper. Allergy 2010, 65:459–466.
38. Ng D: Prescription of codeine in young infants. Hong Kong Med J 2004,
10(6):439.
39. Medicines and Healthcare Products Regulatory Agency: Oral liquid cough
medicines containing codeine: should not be used in children and young
people under 18 years. MHRA Public Assessment Report; 2010. http://www.
mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con096798.
pdf. Last accessed 8 May 2014.40. Carrie AG, Zhanel GG: Antibacterial use in community practice: assessing
quantity, indications and appropriateness, and relationship to the
development of antibacterial resistance. Drugs 1999, 57(6):871–881.
41. McGregor A, Dovey S, Tilyard M: Antibiotic use in upper respiratory tract
infections in New Zealand. Fam Pract 1995, 12(2):166–170.
42. Fagnani F, German-Fattal M: Antibiotic prescribing patterns of French GPs
for upper respiratory tract infections: impact of fusafungine on rates of
prescription of systemic antibiotics. Am J Respir Med 2003, 2(6):491–498.
43. Ashworth M, Cox K, Latinovic R, Charlton J, Gulliford M, Rowlands G: Why
has antibiotic prescribing for respiratory illness declined in primary care?
A longitudinal study using the General Practice Research Database.
J Public Health 2004, 26(3):268–274.
44. Lam T, Lam K: Family doctors’ attitudes towards patient self-
management of upper respiratory tract infections. Hong Kong Med J 2001,
7:146–149.
45. Wong H, Chan E, Wong M, Liang J: Is the number of clinical problems per
consultation correlated with poorer ICPC coding practices in primary
care clinics? A pilot study in two distinct clinic settings. HK Pract 2009,
31:158–165.
46. Wong L, Lee M, Mak H, Wong K, Chung K, Wong K, Tam S, Li H, Chan T,
Kung K, Lam A, Li P: Accuracy and completeness of ICPC coding for
chronic disease in general outpatient clinics. HK Pract 2010, 32:129–135.
47. Wong S, Kung K, Griffiths S, Carthy T, Wong M, Lo S, Chung V, Goggins W,
Starfield B: Comparison of primary care experiences among adults in general
outpatient clinics and private general practice clinics in Hong Kong. BMC
Public Health [Internet] 2010, 10:397. Available from: http://www.biomedcentral.
com/1471-2458/10/397.
doi:10.1186/1471-2296-15-95
Cite this article as: Kung et al.: Patient presentation and physician
management of upper respiratory tract infections: a retrospective
review of over 5 million primary clinic consultations in Hong Kong. BMC
Family Practice 2014 15:95.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
